Analytical chemistry in support of pharmaceutical sciences: a biosensor to identify inhibitors of carbonic anhydrase
Year: 2026
Type: article
Abstract: Background When analytical chemistry meets medicinal chemistry, the identification of promising candidates during drug development might be easier (and cheaper). While conventional enzymatic and chromatographic assays remain the gold standard for evaluating inhibitor potency, they rely on laboratory-based instrumentation and relatively time-consuming workflows. Herein, using carbonic anhydrase (CA) as a representative case study, we report the first portable electrochemical bioplatform, conceived as a comparative analytical triage tool, based on the proton-responsive polyaniline (PANI) transduction layer for the comparative prescreening of CA inhibitor candidates. Results The platform monitors inhibition-induced modulation of CA-catalyzed bicarbonate interconversion through a PANI-modified screen-printed electrode, providing a rapid electrochemical readout in approximately 5 min. The system was assessed using acetazolamide, a benchmark sulfonamide inhibitor, achieving a maximum apparent electrochemical inhibition of approximately 73% at 50 ng mL −1 , under optimized conditions. The platform was subsequently applied to newly synthesized zinc-binding compounds, generating concentration-dependent electrochemical responses and enabling rapid comparative prescreening of structurally diverse candidates. Independent stopped-flow measurements confirmed the weak inhibitory profile of these compounds, supporting the role of the proposed device as a comparative analytical prescreening tool rather than a substitute for conventional kinetic assays. Significance Overall, the platform provides a portable and resource-efficient approach for supporting early analytical triage of newly synthesized compounds, enabling their rapid comparative prioritization before comprehensive biochemical characterization and establishing a practical analytical bridge between medicinal chemistry and downstream inhibitor validation.
Source: Analytica Chimica Acta
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: hybrid
Estimated APC paid: $4,270
OpenAlex ID: W7234529846
